Raluca Verona

Raluca Verona

Company: JnJ

Job title: Senior Director, Head of Immune Oncology & Translational Research


Updated Phase 1 Results of Teclistamab, a B-Cell Maturation Antigen (BCMA) x CD3 Bispecific Antibody, in Relapsed &/or Refractory Multiple Myeloma (RRMM) 10:20 am

Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.